{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:55:51Z","timestamp":1787313351862,"version":"build-2736575974"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":210,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.lrr.2024.100477","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T01:51:02Z","timestamp":1723081862000},"page":"100477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Successful treatment of AML using non-intensive chemotherapy in Jehovah's Witness patients"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9924-2998","authenticated-orcid":false,"given":"David","family":"Page","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sawler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Brandwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lrr.2024.100477_bib0001","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/10428190801911670","article-title":"Acute myeloid leukemia in Jehovah Witnesses","volume":"49","author":"Brown","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.lrr.2024.100477_bib0002","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."},{"issue":"4","key":"10.1016\/j.lrr.2024.100477_bib0003","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bjhh.2016.05.003","article-title":"A clinical challenge: treatment of acute myeloid leukemia in a Jehovah's Witness","volume":"38","author":"Araujo","year":"2016","journal-title":"Rev. Bras. Hematol. Hemoter."},{"issue":"10","key":"10.1016\/j.lrr.2024.100477_bib0004","doi-asserted-by":"crossref","first-page":"E269","DOI":"10.1002\/ajh.25916","article-title":"Venetoclax with azacitidine for two younger Jehovah's Witness patients with high risk acute myeloid leukemia","volume":"95","author":"Bock","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.lrr.2024.100477_bib0005","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/10245332.2017.1411548","article-title":"Antineoplastic chemotherapy in Jehovah's Witness patients with acute myelogenous leukemia refusing blood products \u2013 a matched pair analysis","volume":"23","author":"Wilop","year":"2017","journal-title":"Hematology"},{"issue":"7","key":"10.1016\/j.lrr.2024.100477_bib0006","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.lrr.2024.100477_bib0007","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1300874","article-title":"Retinoic acid and arsenic trioxide for acute promyelocytic leukemia","volume":"369","author":"Lo-Coco","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.lrr.2024.100477_bib0008","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","article-title":"Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet","volume":"133","author":"Sanz","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.lrr.2024.100477_bib0009","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/bjh.16284","article-title":"Treatment of acute leukaemia in adult Jehovah's Witnesses","volume":"190","author":"El Chaer","year":"2020","journal-title":"Br. J. Haematol."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048924000670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048924000670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T15:37:37Z","timestamp":1733413057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048924000670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":9,"alternative-id":["S2213048924000670"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2024.100477","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of AML using non-intensive chemotherapy in Jehovah's Witness patients","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2024.100477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100477"}}